Abstract
Clinical features of systemic lupus erythematosus vary between different parts of the World; however, this information on Nepalese systemic lupus erythematosus does not exist. Patients with systemic lupus erythematosus fulfilling the American College of Rheumatology criteria treated in Patan Hospital were studied by means of retrospective review of their case records. The results were compared with various regional and international studies. The female to male ratio was 36:1 with a mean age at diagnosis 28.67 years. Cutaneous manifestations were the most common 72 (96%) presentations followed by musculoskeletal involvement 70 (93%). Haematological and renal involvements each were present in 33 (44%) of patients. Pulmonary and neuropsychiatric involvements were present in 15 (20%) and 8 (11%) patients respectively. Antinuclear antibody and anti-double stranded deoxyribonucleic acid antibodies were positive in 70 (93%) and 66 (88%) of patients respectively. A quarter of patients had some form of co-morbid conditions. At the time of last follow up, 70 (93%), 66 (90%), and 6 (9%) of patients were taking antimalarials, steroids and immunosuppressive agents respectively, mostly in combinations. Eighty seven percent of patients had their disease activity under control at the time of last follow up whereas four percent still had an active disease. In another four percent died during the course of therapy and the outcome was unknown in another four percent of patients who lost to follow up. Clinical characteristics and antinuclear antibody pattern of Nepalese lupus patients is more or less similar to those with patients from other countries in the region and in the World.
Highlights
Clinical features of Systemic lupus erythematosus vary between different parts of the World; this information on Nepalese Sytemic lupus erythematosus does not exist
While there has been a significant improvement in the survival of these patients over the past four decades, the incidence of Systemic lupus erythematosus (SLE) has nearly tripled in the same period.[2]
More common among people of South Asian origin than Caucasians who reside in Leicester city, England.[5]
Summary
Clinical features of Systemic lupus erythematosus vary between different parts of the World; this information on Nepalese Sytemic lupus erythematosus does not exist. Systemic lupus erythematosus (SLE) is a chronic multi system autoimmune disorder mainly affecting young women.[1] While there has been a significant improvement in the survival of these patients over the past four decades, the incidence of SLE has nearly tripled in the same period.[2]. Paudyal et al Clinical Profile of Patients with Systemic Lupus Erythematosus. More common among people of South Asian origin than Caucasians who reside in Leicester city, England.[5] Serdula and Rhoads’ survey of SLE patients in Hawaii showed the age-adjusted prevalence rates for SLE were significantly higher in Eastern Asians than that in Caucasians.[6] regional differences in the clinical patterns and causes of death in SLE have been described in many countries
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
